Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 8/20 | 0.55 |
| ▸ | S1PR1 | P21453 | 8/20 | 0.55 |
| ▸ | S1PR3 | Q99500 | 8/20 | 0.55 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.55 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.55 |
| ▸ | ANPEP | P15144 | 1/20 | 0.53 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.53 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.43 |
| ▸ | FDPS | P14324 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.41 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.41 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | ADH1B | P00325 | 1/20 | 0.41 |
| ▸ | ADH1C | P00326 | 1/20 | 0.41 |
| ▸ | ADH1A | P07327 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21272054 | 1.00 | S1PR2 (0.55) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL21271959 | 1.00 | S1PR2 (0.55) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL29745012 | 0.98 | S1PR2 (0.52) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL21271938 | 0.92 | S1PR2 (0.44) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL21503939 | 0.88 | S1PR2 (0.62) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL21272019 | 0.88 | S1PR2 (0.62) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL21272097 | 0.86 | S1PR2 (0.60) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL5689630 | 0.85 | S1PR2 (0.59) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL21272210 | 0.85 | S1PR2 (0.58) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL21271951 | 0.84 | ANPEP (0.47) | S1PR2S1PR1S1PR3S1PR4S1PR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260070856-A1 | Concentrated Liquid Compositions of Urease Inhibitors for Nitrogen Sources | SOILGENIC TECH LLC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12497344-B2 | Concentrated liquid compositions of urease inhibitors for nitrogen sources | SOILGENIC TECHNOLOGIES, LLC (US) | 2025-12-16 | — | — | US | disclosed |
| US-12139443-B2 | Concentrated liquid compositions of urease inhibitors for nitrogen sources | SOILGENIC TECHNOLOGIES, LLC (US) | 2024-11-12 | — | — | US | disclosed |
| US-20220242802-A1 | CONCENTRATED LIQUID COMPOSITIONS OF UREASE INHIBITORS FOR NITROGEN SOURCES | SOILGENIC TECHNOLOGIES, LLC | 2022-08-04 | — | — | US | disclosed |
| US-20190256437-A1 | Concentrated Liquid Compositions of Urease Inhibitors for Nitrogen Sources | SOILGENIC TECHNOLOGIES, LLC | 2019-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12497344-B2 | Concentrated liquid compositions of urease inhibitors for nitrogen sources | SRM, DNPH1, UROD | S1PR2 3003/4885S1PR1 3204/4885S1PR3 3524/4885 |
| US-20260070856-A1 | Concentrated Liquid Compositions of Urease Inhibitors for Nitrogen Sources | PNP, UMPS, DNPH1 | S1PR2 4222/4885S1PR1 4334/4885S1PR3 4606/4885 |
| US-20220242802-A1 | CONCENTRATED LIQUID COMPOSITIONS OF UREASE INHIBITORS FOR NITROGEN SOURCES | SRM, DNPH1, UROD | S1PR2 3003/4885S1PR1 3204/4885S1PR3 3524/4885 |
| US-12139443-B2 | Concentrated liquid compositions of urease inhibitors for nitrogen sources | SRM, DNPH1, UROD | S1PR2 3003/4885S1PR1 3204/4885S1PR3 3524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.